Rylo

AI-powered platform offering private, real-time communication solutions for the Deaf and hard-of-hearing community.

Health Tech & Life Sciences
Active
Series B Tel Aviv, Israel Founded 2022
Total raised
$101.0M
Last: Series B 2026-06
Stage
Series B
Founded
2022
Headcount
32
HQ
Tel Aviv, Israel
Sector
Health Tech & Life Sciences

About

Rylo is an AI-powered platform that provides private, real-time communication solutions for the Deaf and hard-of-hearing community. The company's application enables users to conduct phone calls independently through real-time transcription and speech-to-text/text-to-speech, and is expanding into real-time sign language translation. Founded in 2022, Rylo has offices in Tel Aviv, Israel, and New York, and recently raised $85 million in funding.

Funding history · 3 rounds · $101.0M total

Date unknown
Seed $5.0M
2024-07
Series A $11.0M
2026-06
Series B $85.0M

Q&A

What is Rylo's primary focus?
Rylo is an AI-powered platform that provides private, real-time communication solutions for the Deaf and hard-of-hearing community, enabling independent phone calls through real-time transcription and speech-to-text/text-to-speech, and is expanding into real-time sign language translation.
When was Rylo founded and where are its main offices located?
Rylo was founded in 2022 and has offices in Tel Aviv, Israel, and New York.
What was Rylo's most recent funding round?
Rylo completed a Series B funding round in June 2026, raising $85,000,000. The round was led by General Catalyst and Canaan.
What is Rylo's total amount raised to date?
Rylo has raised a total of $101,000,000 across its funding rounds.
Has Rylo made any acquisitions?
Yes, Rylo acquired Sign.mt in December 2025.
Who are the co-founders of Rylo?
Rylo was co-founded by Tomer Aharoni, who serves as CEO, and Alon Ezer, who serves as CTO.
What was Rylo's Series A funding round details?
Rylo raised $11,000,000 in its Series A round in July 2024, with Canaan Partners as a lead investor.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2CB2B

Tags

aicommunicationaccessibilityspeech-to-texttext-to-speechsign-language-translationhealth-tech